Jul 27, 2023
Alecinix150mg(Alectinib) is a medication used for the treatment for non-small cell lung cancer. It works by blocking Anaplastic lymphoma kin
buy non small cell lung cancer medicine at an affordable price
Loading...
seen from Germany
seen from France
seen from United States
seen from United States
seen from Malaysia
seen from Denmark
seen from Malaysia
seen from Germany
seen from United States
seen from United States
seen from Netherlands
seen from Netherlands
seen from Saudi Arabia
seen from China
seen from Netherlands
seen from China
seen from Georgia
seen from Japan
seen from Poland
seen from China
Alecinix150mg(Alectinib) is a medication used for the treatment for non-small cell lung cancer. It works by blocking Anaplastic lymphoma kin
buy non small cell lung cancer medicine at an affordable price
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Alecinix 150 mg (Alectinib)
Presentation Of Alecinix
Alecinix Each capsule contains Alectinib Hydrochloride INN equivalent to Alectinib 150 mg.
Description
Alecinix 150 mg (Alectinib) is a tyrosine kinase inhibitor that targets ALK and RET. In nonclinical studies, Alecinix (Alectinib) inhibited ALK phosphorylation and ALK-mediated activation of the downstream signaling proteins STAT3 and AKT and decreased tumor cell viability in multiple cell lines harboring ALK fusions, amplifications, or activating mutations. The major active metabolite of Alectinib, M4, showed similar in vitro potency and activity.
Alecinix (Alectinib) and M4 demonstrated in vitro and in vivo activity against multiple mutant forms of the ALK enzyme, including some mutations identified in NSCLC tumors in patients who have progressed on Crizotinib.
In mouse models implanted with tumors carrying ALK fusions, administration of Alecinix (Alectinib) resulted in antitumor activity and prolonged survival, including in mouse models implanted intracranially with ALK-driven tumor cell lines.